SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 298 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $401,171 | -14.8% | 14,551 | -7.1% | 0.00% | 0.0% |
| Q2 2023 | $470,589 | +4.3% | 15,655 | +25.7% | 0.00% | -50.0% |
| Q1 2023 | $451,281 | -60.9% | 12,456 | -61.5% | 0.00% | -60.0% |
| Q4 2022 | $1,153,710 | -16.6% | 32,344 | -20.8% | 0.01% | -28.6% |
| Q3 2022 | $1,383,000 | +210.1% | 40,842 | +196.3% | 0.01% | +250.0% |
| Q1 2022 | $446,000 | -55.1% | 13,785 | -59.6% | 0.00% | -33.3% |
| Q4 2021 | $994,000 | +66.8% | 34,092 | +49.8% | 0.00% | 0.0% |
| Q1 2021 | $596,000 | +68.4% | 22,764 | +62.0% | 0.00% | 0.0% |
| Q4 2020 | $354,000 | -54.3% | 14,055 | -62.2% | 0.00% | -70.0% |
| Q3 2020 | $775,000 | -47.1% | 37,187 | -39.8% | 0.01% | -58.3% |
| Q2 2020 | $1,466,000 | +35.6% | 61,731 | +2.7% | 0.02% | -14.3% |
| Q1 2020 | $1,081,000 | -48.8% | 60,108 | -32.5% | 0.03% | +115.4% |
| Q4 2019 | $2,112,000 | +55.4% | 89,031 | +80.0% | 0.01% | +8.3% |
| Q3 2019 | $1,359,000 | +256.7% | 49,452 | +329.1% | 0.01% | +200.0% |
| Q2 2019 | $381,000 | -82.5% | 11,524 | -81.5% | 0.00% | -82.6% |
| Q1 2019 | $2,178,000 | +258.2% | 62,145 | +239.6% | 0.02% | +228.6% |
| Q4 2018 | $608,000 | -30.8% | 18,302 | +5.0% | 0.01% | -36.4% |
| Q3 2018 | $878,000 | -66.1% | 17,436 | -69.2% | 0.01% | -73.2% |
| Q1 2018 | $2,591,000 | +589.1% | 56,569 | +498.8% | 0.04% | +485.7% |
| Q4 2017 | $376,000 | -82.0% | 9,447 | -81.9% | 0.01% | -82.5% |
| Q3 2017 | $2,087,000 | +4.6% | 52,176 | +12.7% | 0.04% | +2.6% |
| Q2 2017 | $1,996,000 | +47.7% | 46,307 | +7.3% | 0.04% | +5.4% |
| Q1 2017 | $1,351,000 | +61.8% | 43,151 | +30.4% | 0.04% | +8.8% |
| Q4 2016 | $835,000 | +245.0% | 33,086 | +178.9% | 0.03% | +126.7% |
| Q2 2016 | $242,000 | -36.5% | 11,861 | -52.5% | 0.02% | -50.0% |
| Q1 2016 | $381,000 | -0.5% | 24,994 | -12.3% | 0.03% | -28.6% |
| Q4 2015 | $383,000 | – | 28,494 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |